Summary and Key Messages
The international panel concluded the only evidence-based indication for testosterone therapy for women is for the treatment of HSDD(Hypoactive sexual desire disorder/dysfunction), with available data supporting a moderate therapeutic effect. There are insufficient data to support the use of testosterone for the treatment of any other symptom or clinical condition, or for disease prevention.